Generation of feline dendritic cells derived from peripheral blood monocytes for in vivo use

Clinical and Diagnostic Laboratory Immunology

Volumn 12, Issue 10, 2005, Pages 1202-1208

  Freer, Giulia ^a   Matteucci, Donatella ^a   Mazzetti, Paola ^a   Bozzacco, Leonia ^a   Bendinelli, Mauro ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; POLYINOSINIC POLYCYTIDYLIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CAT; CELL DIFFERENTIATION; CELLULAR IMMUNITY; COMPLEX FORMATION; DENDRITIC CELL; FELINE IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; IMMUNOTHERAPY; MIXED LYMPHOCYTE REACTION; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VACCINATION; VIRUS INFECTION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, SURFACE; BLOOD CELLS; CATS; CELL CULTURE TECHNIQUES; CULTURE MEDIA; CYTOKINES; DENDRITIC CELLS; FEMALE; IMMUNOPHENOTYPING; METHODS; MONOCYTES;

EID: 26944468620     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.12.10.1202-1208.2005     Document Type: Article

References (29)

1. Bienzle, D., F. Reggeti, M. E. Clark, and C. Chow. 2003. Functional feline dendritic cells derived from blood and bone marrow. Vet. Immunol. Immunopathol. 96:19-30.
2. H1 polarization. Nat. Immunol. 1:305-310.
3. De Smedt, T., B. Pajak, E. Muraille, L. Lespagnard, E. Heinen, P. De Baetselier, J. Urbain, O. Leo, and M. Moser. 1996. Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J. Exp. Med. 184:1413-1424.
4. Dunham, S. P., and J. Bruce. 2004. Isolation, expression and bioactivity of feline granulocyte-macrophage colony-stimulating factor. Gene 332:97-106.
5. Figdor, C. G., I. J. de Vries, W. J. Lesterhuis, and C. J. Melief. 2004. Dendritic cell immunotherapy: mapping the way. Nat. Med. 10:475-480.
6. Freer, G., W. Florio, B. Dalla Casa, D. Bottai, G. Batoni, G. Maisetta, S. Senesi, and M. Campa. 1998. Identification and molecular cloning of a novel secretion antigen from Mycobacterium tuberculosis and Mycobacterium bovis BCG. Res. Microbiol. 149:265-275.
7. Gatti, E., M. A. Velleca, B. C. Biedermann, W. Ma, J. Unternaehrer, M. W. Ebersold, R. Medzhitov, J. S. Pober, and I. Mellman. 2000. Large-scale culture and selective maturation of human Langerhans cells from granulocyte colony-stimulating factor-mobilized CD34+ progenitors. J. Immunol. 164:3600-3607.
8. Geijtenbeek, T. B., R. Torensma, S. J. van Vliet, G. C. van Duijnhoven, G. J. Adema, Y. van Kooyk, and C. G. Figdor. 2000. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100:575-585.
9. Lu, W., X. Wu, Y. Lu, W. Guo, and J. M. Andrieu. 2003. Therapeutic dendritic-cell vaccine for simian AIDS. Nat. Med. 9:27-32.
10. Lu, W., L. C. Arraes, W. T. Ferreira, and J. M. Andrieu. 2004. Therapeutic dendritic-cell vaccine for chronic HIV-1 infection. Nat. Med. 10:1359-1365.
11. Mackensen, A., R. Drager, M. Schlesier, R. Mertelsmann, and A. Lindemann. 2000. Presence of IgE antibodies to bovine serum albumin in a patient developing anaphylaxis after vaccination with human peptide-pulsed dendritic cells. Cancer Immunol. Immunother. 49:152-156.
12. Muller, G., A. Muller, H. Jonuleit, K. Steinbrink, C. Szalma, L. Paragnik, K. Lingnau, E. Schmidt, J. Knop, and A. H. Enk. 2000. Fetal calf serum-free generation of functionally active murine dendritic cells suitable for in vivo therapeutic approaches. J. Investig. Dermatol. 14:142-149.
13. Nair, S., C. McLaughlin, A. Weizer, Z. Su, D. Boczkowski, J. Dannull, J. Vieweg, and E. Gilboa. 2003. Injection of immature dendritic cells into adjuvant-treated skin obviates the need for ex vivo maturation. J. Immunol. 1:6275-6282.
14. Nestle, F. O., S. Alijagic, M. Gilliet, Y. Sun, S. Grabbe, R. Dummer, G. Burg, and D. Schadendorf. 1998. Vaccination of melanoma patients with peptide- or tumor lysate pulsed dendritic cells. Nat. Med. 4:328-332.
15. O'Neill, D., and N. Bhardwaj. 2005. Exploiting dendritic cells for active immunotherapy of cancer and chronic infection. Methods Mol. Med. 109:1-18.
16. Paillot, R., F. Laval, J.-C. Audonnet, C. Andreoni, and V. Juillard. 2001. Functional and phenotypic characterization of distinct porcine dendritic cells derived from peripheral blood monocytes. Immunology 102:396-404.
17. Romani, N., D. Reider, M. Heuer, S. Ebner, E. Kampgen, B. Eibl, D. Niederwieser, and G. Schuler. 1996. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J. Immunol. Methods 196:137-151.
18. Saint-André Marchal, I. C., J.-P. Dezutter-Dambuyant, B. J. Martin, et al. 1997. Quantitative assessment of feline epidermal Langerhans cells Br. J. Dermatol. 136:961-963.
19. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage-colony stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor-a. J. Exp. Med. 179:1109-1118.
20. Sallusto, F., M. Cella, C. Danielli, and A. Lanzavecchia. 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 12:389-400.
21. Sallusto, F., and A. Lanzavecchia. 2002. The instructive role of dendritic cells on T-cell responses. Arthr. Res. 4:S127-S132.
22. Santini, S. M., C. Lapenta, M. Logozzi, S. Parlato, M. Spada, T. Di Pucchio, and F. Belardelli. 2000. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J. Exp. Med. 15:1777-1788.
23. Scheinecker, C., K. P. Machold, O. Majdic, P. Hocker, W. Knapp, and J. S. Smolen. 1998. Initiation of the autologous mixed lymphocyte reaction requires the expression of costimulatory molecules B7-1 and B7-2 on human peripheral blood dendritic cells. J. Immunol. 161:3966-3973.
24. Steinman, R. M., and M. Pope. 2002. Exploiting dendritic cells to improve vaccine efficacy. J. Clin. Investig. 109:1519-1526.
25. + T cell apoptosis. J. Infect. Dis. 185:1077-1093.
26. Verdijk, R. M., T. Mutis, B. Esendam, J. Kamp, C. J. M. Melief, A. Brand, and E. Goulmy. 1999. Polyriboinosinic polyribocytidylic acid (Poly(I:C)) induces stable maturation of functionally active human dendritic cells. J. Immunol. 163:57-61.
27. Willett, B. J., C. A. Cannon, and M. J. Hosie. 2003. Expression of CXCR4 on feline peripheral blood mononuclear cells: effect of feline immunodeficiency virus infection. J. Virol. 77:709-712.
28. Zhou, L. J., and T. F. Tedder. 1995. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J. Immunol. 154:3821-3829.
29. + dendritic cells. Proc. Natl. Acad. Sci. USA 93:2588-2592.